litlas
Log inCreate account

D. Craig Allred

Active 1989–2019

92
Papers
39,723
Citations
87
h-index
92
i10-index

Citations

Citations per year for D. Craig Allred1972: 1 citations1989: 2 citations1990: 3 citations1991: 13 citations1992: 37 citations1993: 38 citations1994: 65 citations1995: 62 citations1996: 63 citations1997: 70 citations1998: 95 citations1999: 99 citations2000: 166 citations2001: 149 citations2002: 145 citations2003: 180 citations2004: 221 citations2005: 290 citations2006: 238 citations2007: 258 citations2008: 334 citations2009: 289 citations2010: 349 citations2011: 450 citations2012: 438 citations2013: 453 citations2014: 471 citations2015: 389 citations2016: 315 citations2017: 324 citations2018: 252 citations2019: 917 citations2020: 896 citations2021: 710 citations2022: 409 citations2023: 282 citations2024: 403 citations2025: 157 citations2026: 7 citations1973–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,812 citing papers, 30.9% of this breakdownUnited Kingdom: 966 citing papers, 7.8% of this breakdownChina: 888 citing papers, 7.2% of this breakdownItaly: 559 citing papers, 4.5% of this breakdownCanada: 541 citing papers, 4.4% of this breakdownGermany: 481 citing papers, 3.9% of this breakdownFrance: 430 citing papers, 3.5% of this breakdownJapan: 390 citing papers, 3.2% of this breakdownSouth Korea: 331 citing papers, 2.7% of this breakdownAustralia: 323 citing papers, 2.6% of this breakdownSpain: 317 citing papers, 2.6% of this breakdownNetherlands: 302 citing papers, 2.5% of this breakdown
0%30.9%Other 24.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology50.3%
  • Medicine43%
  • Computer Science2.3%
  • Immunology and Microbiology1.4%
  • Chemistry0.6%
  • Engineering0.4%
  • Other2%

Topics

  • Breast Cancer Treatment Studies11.1%
  • HER2/EGFR in Cancer Research7.5%
  • Estrogen and related hormone effects4.6%
  • Breast Lesions and Carcinomas3.8%
  • Cancer Cells and Metastasis3.1%
  • Cancer Genomics and Diagnostics2.9%
  • Other67%

Coauthors

All papers

Open in search
  1. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    Authors: M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett, D. Craig Allred, Karen L. Hagerty, Sunil Badve, Patrick L. Fitzgibbons, Glenn Francis, Neil S. Goldstein, Malcolm Hayes, David G. Hicks, Susan C. Lester, Richard R. Love, Pamela B. Mangu, Lisa M. McShane, Keith Miller, C. Kent Osborne, Soonmyung Paik, Jane Perlmutter, Anthony Rhodes, Hironobu Sasano, Jared N. Schwartz, Fred C.G.J. Sweep, Sheila E. Taube, Emina Torlakovic, Paul N. Valenstein, Giuseppe Viale, Daniel W. Visscher, Thomas M. Wheeler, Roger Williams, James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 4,267

  2. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

    Authors: Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, D. Craig Allred, John M.S. Bartlett, Michael Bilous, Patrick L. Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2013 cited by 4,061

  3. Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition

    Authors: Carlos R. Gil Del Alcazar, Sung Jin Huh, Muhammad B. Ekram, Anne Trinh, Lin Liu, Francisco Beça, Xiaoyuan Zi, Minsuk Kwak, Helga Bergholtz, Ying Su, Lina Ding, Hege G. Russnes, Andrea L. Richardson, Kirsten Babski, Elizabeth Min Hui Kim, Charles H. McDonnell, Jon Wagner, Ron Rowberry, Gordon J. Freeman, Deborah Dillon, Thérese Sørlie, Lisa M. Coussens, Judy E. Garber, Rong Fan, Kristie Bobolis, D. Craig Allred, Joon Jeong, So Yeon Park, Franziska Michor, Kornélia Polyák - Cancer Discovery 2017 cited by 242

  4. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Authors: Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Côté, Mitch Dowsett, Patrick L. Fitzgibbons, Wedad Hanna, Amy S. Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine M. Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc J. van de Vijver, Thomas M. Wheeler, Daniel F. Hayes - Archives of Pathology & Laboratory Medicine 2006 cited by 4,475

  5. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)

    Authors: M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett, D. Craig Allred, Karen L. Hagerty, Sunil Badve, Patrick L. Fitzgibbons, Glenn Francis, Neil S. Goldstein, Malcolm Hayes, David G. Hicks, Susan C. Lester, Richard R. Love, Pamela B. Mangu, Lisa M. McShane, Keith Miller, C. Kent Osborne, Soonmyung Paik, Jane Perlmutter, Anthony Rhodes, Hironobu Sasano, Jared N. Schwartz, Fred C.G.J. Sweep, Sheila E. Taube, Emina Torlakovic, Paul N. Valenstein, Giuseppe Viale, Daniel W. Visscher, Thomas M. Wheeler, Roger Williams, James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 1,048

  6. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

    Authors: Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Rodrigo Gonçalves, Souzan Sanati, Chad J. Creighton, Katherine DeSchryver, Erika C. Crouch, Amy Brink, Mark A. Watson, Jingqin Luo, Tao Yu, Michael Barnes, Mitch Dowsett, G. Thomas Budd, Eric P. Winer, Paula Silverman, Laura J. Esserman, Lisa A. Carey, X. Cynthia, Gary Unzeitig, Timothy Pluard, Pat W. Whitworth, Gildy V. Babiera, J. Michael Guenther, Zoneddy Dayao, David M. Ota, Marilyn Leitch, John A. Olson, D. Craig Allred, Kelly K. Hunt - Journal of Clinical Oncology 2017 cited by 411

  7. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

    Authors: Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes - The Lancet Oncology 2009 cited by 1,405

  8. Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

    Authors: Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Lin Li, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie Margenthaler, Gildy V. Babiera, P. Kelly Marcom, Joseph M. Guenther, Mark A. Watson, Marilyn Leitch, Kelly K. Hunt, John A. Olson - Journal of Clinical Oncology 2011 cited by 560

  9. Whole-genome analysis informs breast cancer response to aromatase inhibition

    Authors: Matthew J. Ellis, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, John W. Wallis, Brian Andrew Van Tine, Jeremy Hoog, Reece Goiffon, Theodore C. Goldstein, Sam Ng, Lin Li, Robert J. Crowder, Jacqueline Snider, Karla V. Ballman, Jason D. Weber, Ken Chen, Daniel C. Koboldt, Cyriac Kandoth, William Schierding, Joshua F. McMichael, Christopher A. Miller, Charles Lu, Christopher Harris, Michael D. McLellan, Michael C. Wendl, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie A. Margenthaler, Gildy V. Babiera, P. Kelly Marcom, J. Michael Guenther, Marilyn Leitch, Kelly K. Hunt, John A. Olson, Tao Yu, Christopher A. Maher, Lucinda Fulton, Robert S. Fulton, Michelle Harrison, Ben Oberkfell, Feiyu Du, Ryan Demeter, Tammi L. Vickery, Adnan Elhammali, Helen Piwnica‐Worms, Sandra McDonald, Mark A. Watson, David J. Dooling, David M. Ota, Li-Wei Chang, Ron Bose, Timothy J. Ley, David Piwnica‐Worms, Joshua M. Stuart, Richard K. Wilson, Elaine R. Mardis - Nature 2012 cited by 1,035

  10. Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

    Authors: D. Craig Allred, Jennet Harvey, Melora D. Berardo, Clark Gm - 1998 cited by 2,169

  11. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

    Authors: Jennet Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred - Journal of Clinical Oncology 1999 cited by 2,063

  12. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ

    Authors: Fariba Behbod, Frances Kittrell, Heather L. LaMarca, David G. Edwards, Sofia Kerbawy, Jessica Heestand, Evelin Young, Purna Mukhopadhyay, Hung‐Wen Yeh, D. Craig Allred, Min Hu, Kornélia Polyák, Jeffrey M. Rosen, Daniel Medina - Breast Cancer Research 2009 cited by 298

  13. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

    Authors: D. Craig Allred, Stewart Anderson, Soonmyung Paik, D. Lawrence Wickerham, Irıs D. Nagtegaal, Sandra M. Swain, Elefetherios P. Mamounas, Thomas B. Julian, Charles E. Geyer, Joseph P. Costantino, Stephanie R. Land, Norman Wolmark - Journal of Clinical Oncology 2012 cited by 360

  14. Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

    Authors: Richard J. Santen, D. Craig Allred, Stacy P. Ardoin, David F. Archer, Norman F. Boyd, Glenn D. Braunstein, Henry Burger, Graham A. Colditz, Susan R. Davis, Marco Gambacciani, Barbara A. Gower, Victor W. Henderson, Wael Jarjour, Richard H. Karas, Michael Kleerekoper, Roger A. Lobo, JoAnn E. Manson, Jo Marsden, Kathryn A. Martin, Lisa J. Martin, JoAnn V. Pinkerton, David R. Rubinow, Helena Teede, Diane Thiboutot, Wulf H. Utian - The Journal of Clinical Endocrinology & Metabolism 2010 cited by 678

  15. Ductal Carcinoma In Situ: Terminology, Classification, and Natural History

    Authors: D. Craig Allred - JNCI Monographs 2010 cited by 219

  16. Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

    Authors: C. Kent Osborne, V J Bardou, Torsten Hopp, Gary C. Chamness, Susan G. Hilsenbeck, Suzanne A.W. Fuqua, Jiemin Wong, D. Craig Allred, Gary M. Clark, R. Schiff - JNCI Journal of the National Cancer Institute 2003 cited by 782

  17. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

    Authors: Jenny C. Chang, Eric C. Wooten, Anna Tsimelzon, Susan G. Hilsenbeck, Maya Gutierrez, Richard Elledge, Syed K. Mohsin, C. Kent Osborne, Gary C. Chamness, D. Craig Allred, P. O’Connell - The Lancet 2003 cited by 885

  18. Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

    Authors: Maya Gutierrez, Simone Detre, Stephen Johnston, Syed K. Mohsin, Jiang Shou, D. Craig Allred, Rachel Schiff, C. Kent Osborne, Mitch Dowsett - Journal of Clinical Oncology 2005 cited by 489

  19. Invasive Breast Cancer

    Authors: Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Andres Forero, Sharon H. Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Britt‐Marie Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth Reed, Jasgit C. Sachdev, Mary Lou Smith, George Somlo, John H. Ward, Antonio C. Wolff, Richard C. Zellars - Journal of the National Comprehensive Cancer Network 2011 cited by 154

  20. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry

    Authors: D. Craig Allred, Robert W. Carlson, Donald A. Berry, Harold J. Burstein, Stephen B. Edge, Lori J. Goldstein, Allen M. Gown, M. Elizabeth Hammond, J. Dirk Iglehart, Susan J. Moench, Lori J. Pierce, Peter M. Ravdin, Stuart J. Schnitt, Antonio C. Wolff - Journal of the National Comprehensive Cancer Network 2009 cited by 142

  21. PIK3CA Mutations in In situ and Invasive Breast Carcinomas

    Authors: Alexander Miron, Mária Váradi, Daniel R. Carrasco, Hailun Li, Lauren Luongo, Hee Jung Kim, So Yeon Park, Eun Yoon Cho, Gretchen Lewis, Sarah M. Kehoe, J. Dirk Iglehart, Deborah Dillon, D. Craig Allred, Laura E. MacConaill, Rebecca Gelman, Kornélia Polyák - Cancer Research 2010 cited by 131

  22. Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

    Authors: D. Craig Allred, Gary M. Clark, Richard Elledge, Suzanne A.W. Fuqua, Richard W. Brown, Gary C. Chamness, C. Kent Osborne, William McGuire - JNCI Journal of the National Cancer Institute 1993 cited by 783

  23. Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer

    Authors: D. Craig Allred - Modern Pathology 2010 cited by 185

  24. Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer

    Authors: Sangjun Lee, Sheila A. Stewart, Irıs D. Nagtegaal, Jingqin Luo, Yun Wu, Graham A. Colditz, Dan Medina, D. Craig Allred - Cancer Research 2012 cited by 154